AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
AVANT Gets Patent Protection For Intellectual Property Of Anticholesterol Agent.(AVANT Immunotherapeutics Inc. has patent for CETi-1)
2001 OCT 17 - (NewsRx.com & NewsRx.net) -- AVANT Immunotherapeutics Inc. (AVAN) has received a U.S. patent covering DNA immunogenic compositions for modulating endogenous cholesteryl ester transfer protein (CETP). The company also signed an agreement with the Immune Response Corp. (IMNR) to acquire a portfolio of granted and pending patents covering products or methods for stimulating an immune response against CETP.
AVANT's cholesterol management agent, CETi-1, is designed to raise serum HDL (high-density lipoprotein) cholesterol levels by blocking the transfer of cholesterol from HDL to LDL (low-density lipoprotein). CETi-1 induces antibodies against a portion of CETP, the serum protein responsible for this transfer. ...
- New Research Illustrates Role of CETP in Atherosclerosis; Supports Concept Of...
- Press release article from: PR Newswire November 29, 1999 700+ words
...transfer protein (CETP) can promote...development by AVANT Immunotherapeutics, Inc. (Nasdaq...human gene for CETP in a rat strain...Officer of AVANT Immunotherapeutics. In preliminary...of AVANT's CETP vaccine, treated...
- AVANT Immunotherapeutics Receives a Tibbetts Award From The U.S. Small Business...
- Press release article from: PR Newswire October 27, 1999 700+ words
...transfer protein (CETP). AVANT Immunotherapeutics, Inc. is developing...vaccine to inhibit CETP function. It is...preclinical studies of the CETP vaccine, treated...In June of 1999, AVANT Immunotherapeutics, Inc. began enrollment...
- AVANT Immunotherapeutics Receives Additional Key Patent for Its Cholesterol...
- Press release article from: Business Wire April 29, 2003 700+ words
...April 29, 2003 AVANT Immunotherapeutics, Inc. (Nasdaq...of AVANT's novel CETP vaccine technology...HDL and decreasing CETP activity," said...control the activity of CETP, which transfers...atherosclerosis. AVANT Immunotherapeutics is engaged in the...
- Results of a Phase I and Extension Study of AVANT Immunotherapeutics' Novel...
- Press release article from: Business Wire July 17, 2003 700+ words
...development by AVANT Immunotherapeutics (Nasdaq...protein (CETP) vaccine...Officer of AVANT Immunotherapeutics. She commented...inhibitors of CETP had shown reductions in CETP activity...therapy." AVANT Immunotherapeutics is engaged...
- Avant Immunotherapeutics Receives Key Patent for Its Cholesterol Management...
- Press release article from: Business Wire June 25, 2002 700+ words
...Writers BIOWIRE2K AVANT Immunotherapeutics, Inc. (Nasdaq...transfer protein (CETP), a serum protein...to inhibiting CETP. AVANT's expanded CETP vaccine patent...western world. AVANT Immunotherapeutics, Inc. is engaged...
- AVANT Immunotherapeutics Announces Positive Phase II Trial Results of Its...
- Press release article from: Business Wire October 22, 2003 700+ words
...Oct. 22, 2003 AVANT Immunotherapeutics, Inc. (Nasdaq...designed to elicit anti-CETP antibodies in an extremely...antibodies against CETP can produce an effect...transfer protein (CETP). Atherosclerosis...cost of therapy." AVANT Immunotherapeutics is engaged in the...
- AVANT Immunotherapeutics Reports First Quarter 2003 Financial Results.
- Press release article from: Business Wire April 30, 2003 700+ words
...BUSINESS WIRE)--April 30, 2003 AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today...and Chief Financial Officer of AVANT Immunotherapeutics, Inc. "The delay in the award...and Chief Executive Officer of AVANT Immunotherapeutics, Inc. "This contract is very...
- AVANT Immunotherapeutics Reports Second Quarter 2002 Financial Results.
- Press release article from: Business Wire July 24, 2002 700+ words
...July 24, 2002 AVANT Immunotherapeutics, Inc. (Nasdaq...Financial Officer of AVANT Immunotherapeutics, Inc. "We...transfer protein (CETP). In addition...several minutes. AVANT Immunotherapeutics, Inc. is engaged...